JBI Revenue and Competitors

North Adelaide, Australia

Location

N/A

Total Funding

Employee Data

  • JBI has 65 Employees.(i)
  • JBI grew their employee count by 20% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2-50%N/AN/A
#2
N/A3846%N/AN/A
#3
N/A6520%N/AN/A
#4
N/A34N/AN/AN/A
#5
$7.5M14810%N/AN/A
#6
$3.5M19-17%N/AN/A
#7
N/A120%N/AN/A
#8
N/A5423%N/AN/A
#9
N/A205%N/AN/A
#10
$1.7M20-5%N/AN/A
Add Company

What Is JBI?

JBI is a global organisation promoting and supporting evidence-based decisions that improve health and health service delivery.\n\nJBI offers a unique range of solutions to access, appraise and apply the best available evidence.\n\nJBI is driven to improving health outcomes in communities globally by promoting and supporting the use of the best available evidence to inform decisions made at the point of care. This work begins and ends with the needs of those working in and using healthcare services.\n\nJBI responds to their questions and provides high quality, reliable information that is pragmatic and useful where it counts. This information is based on evidence that is feasible, appropriate, meaningful and effective to specific populations and settings. JBI achieves this by working with universities and hospitals from across the globe through the JBI Collaboration. In doing so JBI ensures that the research evidence we seek to synthesise, transfer and implement is culturally inclusive and relevant across the diversity of healthcare internationally.\n\nJBI promotes and supports the sustainability of improved healthcare practice and health outcomes globally by developing and delivering a range of unique evidence-based resources, software, education and training.\n\nContact us:\njbi@adelaide.edu.au\n61-8-8313 4880

keywords:N/A

N/A

Total Funding

65

Number of Employees

N/A

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.2M841%N/A
#2
$40.7M2558%N/A
#3
$45.6M2599%N/A
#4
$112.1M332N/AN/A
#5
$117.1M3477%N/A